148 related articles for article (PubMed ID: 23082735)
1. Chemotherapy: What is its role in meningioma?
Sherman WJ; Raizer JJ
Expert Rev Neurother; 2012 Oct; 12(10):1189-95; quiz 1196. PubMed ID: 23082735
[TBL] [Abstract][Full Text] [Related]
2. Medical treatment of recurrent meningiomas.
Chamberlain MC; Barnholtz-Sloan JS
Expert Rev Neurother; 2011 Oct; 11(10):1425-32. PubMed ID: 21955199
[TBL] [Abstract][Full Text] [Related]
3. The role of chemotherapy and targeted therapy in the treatment of intracranial meningioma.
Chamberlain MC
Curr Opin Oncol; 2012 Nov; 24(6):666-71. PubMed ID: 22759739
[TBL] [Abstract][Full Text] [Related]
4. Hydroxyurea chemotherapy in the treatment of meningiomas.
Newton HB
Neurosurg Focus; 2007; 23(4):E11. PubMed ID: 17961035
[TBL] [Abstract][Full Text] [Related]
5. Treatment of high risk or recurrent meningiomas with hydroxyurea.
Rosenthal MA; Ashley DL; Cher L
J Clin Neurosci; 2002 Mar; 9(2):156-8. PubMed ID: 11922703
[TBL] [Abstract][Full Text] [Related]
6. Novel therapies for meningiomas.
Wen PY; Drappatz J
Expert Rev Neurother; 2006 Oct; 6(10):1447-64. PubMed ID: 17078786
[TBL] [Abstract][Full Text] [Related]
7. Recent developments in chemotherapy for meningiomas: a review.
Moazzam AA; Wagle N; Zada G
Neurosurg Focus; 2013 Dec; 35(6):E18. PubMed ID: 24289126
[TBL] [Abstract][Full Text] [Related]
8. Targeted drug therapy for meningiomas.
Norden AD; Drappatz J; Wen PY
Neurosurg Focus; 2007; 23(4):E12. PubMed ID: 17961036
[TBL] [Abstract][Full Text] [Related]
9. Hydroxyurea for treatment of unresectable meningiomas.
Schrell UM; Rittig MG; Koch U; Marschalek R; Anders M
Lancet; 1996 Sep; 348(9031):888-9. PubMed ID: 8826822
[No Abstract] [Full Text] [Related]
10. Hydroxyurea for treatment of unresectable and recurrent meningiomas. I. Inhibition of primary human meningioma cells in culture and in meningioma transplants by induction of the apoptotic pathway.
Schrell UM; Rittig MG; Anders M; Kiesewetter F; Marschalek R; Koch UH; Fahlbusch R
J Neurosurg; 1997 May; 86(5):845-52. PubMed ID: 9126901
[TBL] [Abstract][Full Text] [Related]
11. Spinal meningioma during hydroxyurea therapy. A paradoxycal case report.
Giordano F; Savarino A; Pagni CA
Neurol Sci; 2002 Sep; 23(3):127-9. PubMed ID: 12391498
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma.
Norden AD; Ligon KL; Hammond SN; Muzikansky A; Reardon DA; Kaley TJ; Batchelor TT; Plotkin SR; Raizer JJ; Wong ET; Drappatz J; Lesser GJ; Haidar S; Beroukhim R; Lee EQ; Doherty L; Lafrankie D; Gaffey SC; Gerard M; Smith KH; McCluskey C; Phuphanich S; Wen PY
Neurology; 2015 Jan; 84(3):280-6. PubMed ID: 25527270
[TBL] [Abstract][Full Text] [Related]
13. Treatment for rare brain tumors veers from traditional tack.
McBride G
J Natl Cancer Inst; 1997 Jul; 89(13):912-3. PubMed ID: 9214668
[No Abstract] [Full Text] [Related]
14. Medical Management of Meningiomas: Current Status, Failed Treatments, and Promising Horizons.
Karsy M; Guan J; Cohen A; Colman H; Jensen RL
Neurosurg Clin N Am; 2016 Apr; 27(2):249-60. PubMed ID: 27012389
[TBL] [Abstract][Full Text] [Related]
15. Calcium channel antagonists augment hydroxyurea- and ru486-induced inhibition of meningioma growth in vivo and in vitro.
Ragel BT; Gillespie DL; Kushnir V; Polevaya N; Kelly D; Jensen RL
Neurosurgery; 2006 Nov; 59(5):1109-20; discussion 1120-1. PubMed ID: 17143245
[TBL] [Abstract][Full Text] [Related]
16. Hydroxyurea with or without imatinib in the treatment of recurrent or progressive meningiomas: a randomized phase II trial by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).
Mazza E; Brandes A; Zanon S; Eoli M; Lombardi G; Faedi M; Franceschi E; Reni M
Cancer Chemother Pharmacol; 2016 Jan; 77(1):115-20. PubMed ID: 26659583
[TBL] [Abstract][Full Text] [Related]
17. Hydroxyurea for treatment of meningioma.
Cusimano MD
J Neurosurg; 1998 May; 88(5):938-9. PubMed ID: 9576275
[No Abstract] [Full Text] [Related]
18. Hydroxyurea chemotherapy for meningiomas: enlarged cohort with extended follow-up.
Newton HB; Scott SR; Volpi C
Br J Neurosurg; 2004 Oct; 18(5):495-9. PubMed ID: 15799152
[TBL] [Abstract][Full Text] [Related]
19. Comment: Medical therapy for recurrent or progressive meningiomas remains elusive.
Iwamoto FM
Neurology; 2015 Jan; 84(3):285. PubMed ID: 25527267
[No Abstract] [Full Text] [Related]
20. Reapprasial of the role of endocrine therapy in meningioma management.
Chargari C; Védrine L; Bauduceau O; Le Moulec S; Ceccaldi B; Magné N
Endocr Relat Cancer; 2008 Dec; 15(4):931-41. PubMed ID: 18632875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
